About the Company
We do not have any company description for DICE Therapeutics Inc at the moment.
Exchange
NASDAQ
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $DICE News
Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics
DICE Therapeutics Inc is a biopharmaceutical company leveraging proprietary technology platform to build a pipeline of novel oral therapeutic candidates to treat chronic diseases in immunology and ...
DICE Therapeutics To Participate At Upcoming Investor Conferences
About DICE Therapeutics, Inc. DICE Therapeutics, Inc. is a biopharmaceutical company leveraging its proprietary technology platform to build a pipeline of novel oral therapeutic candidates to ...
DMAC DiaMedica Therapeutics Inc.
DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, focuses on improving the lives of people suffering from serious diseases with a focus on acute ischemic stroke. The company ...
12 Best Biotech Penny Stocks to Invest In
One indication of this optimism is the performance of biotech giants like GlaxoSmithKline plc (NYSE:GSK), Eli Lilly and Company (NYSE:LLY), and AbbVie Inc ... of DICE Therapeutics, POINT Biopharma ...
Michael P. Rubin's Net Worth
This is based on reported shares across multiple companies, which include Vigil Neuroscience, Inc., DICE Therapeutics, Inc., IsoPlexis Corp, and Telesis Bio Inc.. Attention insiders: Dive deeper ...
Omega Therapeutics Inc OMGA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Kintara Therapeutics Inc KTRA
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...
Seres Therapeutics Inc (MCRB) Reports Encouraging Sales Growth and Strategic Cost Savings in 2023
Warning! GuruFocus has detected 8 Warning Signs with MCRB. On March 5, 2024, Seres Therapeutics Inc (NASDAQ:MCRB) released its 8-K filing, announcing the fourth quarter and full year financial ...
OTLK Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. Its lead ...
Akero Therapeutics Inc (AKRO)
Jonathan Young, the Chief Operating Officer of Akero Therapeutics, Inc. (NASDAQ:AKRO), has recently sold shares of the company's common stock, generating over $18,000 in the... Akero Therapeutics ...
12 Best Biotech Penny Stocks to Invest In
In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these ...
Loading the latest forecasts...